PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma

Jung Woo Choi, Ju Han Lee, Hong Seok Park, Young Sik Kim

    Research output: Contribution to journalArticlepeer-review

    9 Citations (Scopus)


    Aims: To characterise patients with high plasminogen activator inhibitor-1 (PAI-1) expression as oral PAI-1 antagonists are currently in preclinical trials, and to determine whether the PAI-1 promoter 4G/5G polymorphism regulates PAI-1 expression in clear cell renal cell carcinoma (CCRCC). Methods: PAI-1 expression was examined by immunohistochemistry in 69 CCRCC specimens. In addition, the promoter 4G/5G polymorphism was investigated by both allele-specific PCR and direct DNA sequencing. Results: PAI-1 was overexpressed in 25/69 (36.2%) patients with CCRCC. PAI-1 staining was intense in tumour cells with a high Fuhrman nuclear grade and in spindle-shaped tumour cells. PAI-1 expression was significantly associated with older age at diagnosis (p=0.027), high nuclear grade (p<0.001), advanced clinical stage (p=0.030) and distant metastasis (p=0.009). In survival analyses, PAI-1 expression was correlated with disease-free survival in Kaplan-Meier curves (p=0.015) but was not significant in the Cox hazards model (p=0.527). The frequencies of the promoter polymorphism were 24.6% (17/69) 4G/4G, 43.5% (30/69) 4G/5G and 31.9% (22/69) 5G/5G. The homozygous 4G/4G or 5G/5G group showed a tendency for a high nuclear grade (p=0.05) but the 4G/5G polymorphism was not related to other prognostic parameters. PAI-1 expression was poorly correlated with its promoter 4G/5G polymorphism (Spearman ρ=0.088). Conclusions: CCRCC with high PAI-1 expression is characterised by older age, high nuclear grade, advanced stage, distant metastasis and/or shortened disease-free survival. PAI-1 expression is not affected by the promoter 4G/5G polymorphism.

    Original languageEnglish
    Pages (from-to)893-897
    Number of pages5
    JournalJournal of Clinical Pathology
    Issue number10
    Publication statusPublished - 2011 Oct

    ASJC Scopus subject areas

    • Pathology and Forensic Medicine


    Dive into the research topics of 'PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma'. Together they form a unique fingerprint.

    Cite this